🇺🇸 ABCD in United States

4 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 4

Most-reported reactions

1. Eye Pain — 1 report (25%)
2. Ocular Hyperaemia — 1 report (25%)
3. Photophobia — 1 report (25%)
4. Swelling Of Eyelid — 1 report (25%)

Source database →

Frequently asked questions

Is ABCD approved in United States?

ABCD does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for ABCD in United States?

CSPC Ouyi Pharmaceutical Co., Ltd. is the originator. The local marketing authorisation holder may differ — check the official source linked above.